Laboratorios Farma | ROVI - Pre Tax Profit

Stock Price
79.70
Daily Change
-1.00 -1.24%
Monthly
-0.13%
Yearly
55.06%
Q2 Forecast
79.04

Laboratorios Farma reported EUR26.78M in Pre-Tax Profit for its fiscal semester ending in June of 2025.





Pre Tax Profit Change Date
Akebia Therapeutics USD -11.24M 12.39M Dec/2025
Alaunos Therapeutics USD -7.84M 633K Dec/2023
Almirall EUR 30.32M 22M Dec/2025
Avita Medical AUD -11.64M 12.13M Dec/2025
Dianthus Therapeutics USD -64.43M 27.67M Dec/2025
Ionis Pharmaceuticals USD -228M 99M Dec/2025
IQVIA Holdings USD 537M 5.62B Dec/2025
Laboratorios Farma EUR 26.78M 94.77M Jun/2025
Moderna USD -187M 631M Sep/2025
Organon & Co USD 243M 14M Sep/2025
Pharma Mar EUR 40.2M 44.28M Dec/2025
Revvity USD 55.68M 115.97M Sep/2025
Tectonic Therapeutic USD -18.97M 63K Dec/2025
Viatris USD -7.9M 209.2M Sep/2025
Xeris Pharmaceuticals USD 11.08M 10.46M Dec/2025